Vliv omeprazolu na hojení duodenálního vredu, Helicobacter pylori a gastritidy
[The effect of omeprazole on healing of duodenal ulcers, Helicobacter pylori and gastritis]
Jazyk čeština Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
8358765
- MeSH
- dvanáctníkové vředy farmakoterapie mikrobiologie patologie MeSH
- gastritida farmakoterapie mikrobiologie patologie MeSH
- Helicobacter pylori * účinky léků izolace a purifikace MeSH
- infekce vyvolané Helicobacter pylori farmakoterapie patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- omeprazol terapeutické užití MeSH
- žaludek mikrobiologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- omeprazol MeSH
Losec (omeprazole) Astra Co. is a blocker of the proton pump of the parietal cell. It inhibits basal and stimulated HCl secretion. It is used for treatment of gastroduodenal ulcers, reflux oesophagitis and Zollinger Ellison's syndrome. In a group of 17 patients with duodenal ulcers the authors investigated the effect of omeprazole on (1) healing of duodenal ulcers and bulbitis after 2-4 weeks of therapy, (2) elimination of Helicobacter pylori in the antrum, (3) chronic antral gastritis. Ad 1. After two weeks of treatment the authors found that 5 of 17 chronic duodenal ulcers were healed in the remainder substantial regression was found. Four-week treatment led to healing of 16 from a total of 17 ulcers (P < 0.001), i. e. 94%. In subjects with ulcers and bulbitis (12 patients) the ulcer healed in 11 instances, in 7 patients residual bulbitis persisted. Ad 2. H. pylori was detected before treatment in 16 of 17 patients, after treatment only in 5 (P < 0.001). Ad 3. Chronic gastritis was recorded before treatment in all patients. Treatment reduced its activity and the presence of H. pylori.